Next Generation Cancer Treatment Development
Official title: NexTGen - DFCI
Funded at Dana-Farber Cancer Inst · NIH-10931252 · Data updated 2026-11-12
This study is looking for new and better ways to treat cancer, and it invites patients to try out exciting new therapies that could work better and have fewer side effects than what’s currently available.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 26, 2023 |
| Project end | May 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $916,494 |
| NIH project number | 1OT2CA291436-01 |
| Project ID | NIH-10931252 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would include individuals diagnosed with cancer who are seeking new treatment options.
✕Less likely to help
Patients with conditions unrelated to cancer may not receive any benefit from this research.
What this research studies
This research focuses on advancing innovative cancer treatment strategies through the development of next-generation therapies. The approach involves collaboration among experts to explore new methodologies and technologies that could enhance patient outcomes. Patients may be involved in trials that test these novel treatments, which aim to improve efficacy and reduce side effects compared to existing options.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments for patients.
How similar studies have gone: Other research in the field of cancer treatment has shown promising results with innovative approaches, indicating potential for success in this area.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Majzner, Robbie G. — Dana-Farber Cancer Inst
- Study coordinator: Majzner, Robbie G.
Related research
Other NIH-funded projects on the same topics.
-
Helping young people with cancer understand their genetic risks
This study is creating a special program to help teenagers and young adults with hereditary cancer risks learn about their health and make smart choices, while also supporting their families along the way.
-
Core administrative hub for a multifaceted cancer center program
A large, international cancer research program at Dana-Farber aims to advance a curative strategy for multiple myeloma by coordinating translational research, clinical trials, and data analysis.
-
Automated, interactive lab tool to define radiation targets in cancer care
Aims to make it easier and safer to outline the area to treat in radiation therapy for cancers by using smart software and a patient-friendly interface.
-
Cancer Atlas Network data hub to share big cancer data
A national project helps researchers store, harmonize, and share large cancer data collections so doctors and scientists can learn from many patients.
-
Bridge-building cancer research partnership for education, outreach, and science
A joint effort between UMass Boston and Harvard Cancer Consortium to accelerate cancer research and education by connecting lower-resourced institutions with a leading cancer center.
-
NexTGen: Next-Generation T cell therapy for childhood cancers
A charity-friendly overview: researchers at Dana-Farber are developing advanced engineered T-cell therapies to treat pediatric solid cancers like brain tumors and sarcomas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.